CVS Health Corp (NYSE:CVS) is Gyroscope Capital Management Group LLC’s 4th Largest Position

Share on StockTwits

Gyroscope Capital Management Group LLC reduced its stake in shares of CVS Health Corp (NYSE:CVS) by 8.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 144,420 shares of the pharmacy operator’s stock after selling 14,189 shares during the quarter. CVS Health accounts for 3.5% of Gyroscope Capital Management Group LLC’s holdings, making the stock its 4th largest position. Gyroscope Capital Management Group LLC’s holdings in CVS Health were worth $8,841,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in CVS. Buckhead Capital Management LLC increased its stake in shares of CVS Health by 49.8% in the first quarter. Buckhead Capital Management LLC now owns 138,793 shares of the pharmacy operator’s stock worth $7,485,000 after buying an additional 46,118 shares during the period. Pendal Group Ltd purchased a new position in shares of CVS Health in the first quarter worth $59,000. Ironwood Investment Counsel LLC increased its stake in shares of CVS Health by 11.3% in the first quarter. Ironwood Investment Counsel LLC now owns 48,197 shares of the pharmacy operator’s stock worth $2,599,000 after buying an additional 4,893 shares during the period. Mathes Company Inc. increased its stake in shares of CVS Health by 61.0% in the first quarter. Mathes Company Inc. now owns 14,250 shares of the pharmacy operator’s stock worth $769,000 after buying an additional 5,400 shares during the period. Finally, NJ State Employees Deferred Compensation Plan increased its stake in shares of CVS Health by 37.8% in the first quarter. NJ State Employees Deferred Compensation Plan now owns 43,766 shares of the pharmacy operator’s stock worth $2,360,000 after buying an additional 12,000 shares during the period. Institutional investors own 75.91% of the company’s stock.

In other news, EVP Joshua Matthew Flum sold 17,703 shares of CVS Health stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $63.00, for a total value of $1,115,289.00. Following the completion of the transaction, the executive vice president now owns 36,163 shares of the company’s stock, valued at approximately $2,278,269. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Eva C. Boratto sold 8,130 shares of CVS Health stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $65.00, for a total value of $528,450.00. Following the completion of the transaction, the chief financial officer now directly owns 55,273 shares of the company’s stock, valued at approximately $3,592,745. The disclosure for this sale can be found here. 0.53% of the stock is owned by insiders.

Shares of CVS stock traded up $1.30 during mid-day trading on Friday, reaching $63.44. 257,649 shares of the company’s stock traded hands, compared to its average volume of 6,237,457. CVS Health Corp has a 12 month low of $51.72 and a 12 month high of $82.15. The company has a market cap of $78.52 billion, a P/E ratio of 8.96, a P/E/G ratio of 1.32 and a beta of 0.86. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The company’s 50-day moving average price is $62.12 and its 200-day moving average price is $56.71.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Zacks’ consensus estimate of $1.70 by $0.19. The firm had revenue of $63.43 billion for the quarter, compared to analysts’ expectations of $62.66 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The company’s quarterly revenue was up 35.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.69 EPS. Equities analysts predict that CVS Health Corp will post 6.97 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 4th. Stockholders of record on Thursday, October 24th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.15%. The ex-dividend date is Wednesday, October 23rd. CVS Health’s dividend payout ratio is presently 28.25%.

Several research analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of CVS Health from $74.00 to $77.00 and gave the stock an “overweight” rating in a research note on Thursday, September 26th. ValuEngine raised shares of CVS Health from a “strong sell” rating to a “sell” rating in a research note on Wednesday, October 2nd. TheStreet upgraded shares of CVS Health from a “c+” rating to a “b-” rating in a report on Monday, September 9th. Royal Bank of Canada began coverage on shares of CVS Health in a report on Friday, September 27th. They issued an “outperform” rating and a $85.00 price target on the stock. Finally, Deutsche Bank began coverage on shares of CVS Health in a report on Thursday, September 12th. They issued a “buy” rating and a $91.00 price target on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $75.39.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: Initial Coin Offering (ICO)

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.